Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study examines the pharmacokinetic profile of Armstrong's proposed Epinephrine
Inhalation Aerosol USP, an HFA-MDI (E004), in healthy male and female adult volunteers.
Safety of E004 will also be evaluated, under augmented dose conditions.